Tekla Life Sciences Stock Probability of Future Stock Price Finishing Under 12.53
| HQL Stock | USD 13.83 0.47 3.29% |
Tekla |
Tekla Life Target Price Odds to finish below 12.53
The tendency of Tekla Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to $ 12.53 or more in 90 days |
| 13.83 | 90 days | 12.53 | near 1 |
Based on a normal probability distribution, the odds of Tekla Life to drop to $ 12.53 or more in 90 days from now is near 1 (This Tekla Life Sciences probability density function shows the probability of Tekla Stock to fall within a particular range of prices over 90 days) . Probability of Tekla Life Sciences price to stay between $ 12.53 and its current price of $13.83 at the end of the 90-day period is near 1 .
Considering the 90-day investment horizon Tekla Life has a beta of 0.66. This usually indicates as returns on the market go up, Tekla Life average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Tekla Life Sciences will be expected to be much smaller as well. Additionally Tekla Life Sciences has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Tekla Life Price Density |
| Price |
Predictive Modules for Tekla Life
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Tekla Life Sciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Tekla Life Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Tekla Life is not an exception. The market had few large corrections towards the Tekla Life's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Tekla Life Sciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Tekla Life within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.22 | |
β | Beta against Dow Jones | 0.66 | |
σ | Overall volatility | 0.36 | |
Ir | Information ratio | -0.21 |
Tekla Life Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Tekla Life for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Tekla Life Sciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Tekla Life Sciences generated a negative expected return over the last 90 days | |
| Tekla Life Sciences has high likelihood to experience some financial distress in the next 2 years | |
| Tekla Life Sciences has about 292.4 K in cash with (12.8 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| On 30th of September 2024 Tekla Life paid $ 0.49 per share dividend to its current shareholders | |
| Latest headline from seekingalpha.com: abrdn Life Sciences Investors declares 0.50 dividend |
Tekla Life Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Tekla Stock often depends not only on the future outlook of the current and potential Tekla Life's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Tekla Life's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 26.8 M | |
| Cash And Short Term Investments | 15.2 M |
Tekla Life Technical Analysis
Tekla Life's future price can be derived by breaking down and analyzing its technical indicators over time. Tekla Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Tekla Life Sciences. In general, you should focus on analyzing Tekla Stock price patterns and their correlations with different microeconomic environments and drivers.
Tekla Life Predictive Forecast Models
Tekla Life's time-series forecasting models is one of many Tekla Life's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Tekla Life's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Tekla Life Sciences
Checking the ongoing alerts about Tekla Life for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Tekla Life Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Tekla Life Sciences generated a negative expected return over the last 90 days | |
| Tekla Life Sciences has high likelihood to experience some financial distress in the next 2 years | |
| Tekla Life Sciences has about 292.4 K in cash with (12.8 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| On 30th of September 2024 Tekla Life paid $ 0.49 per share dividend to its current shareholders | |
| Latest headline from seekingalpha.com: abrdn Life Sciences Investors declares 0.50 dividend |
Check out Tekla Life Backtesting, Tekla Life Valuation, Tekla Life Correlation, Tekla Life Hype Analysis, Tekla Life Volatility, Tekla Life History as well as Tekla Life Performance. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tekla Life. If investors know Tekla will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tekla Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.425 | Dividend Share 1.3 | Earnings Share 1.34 | Revenue Per Share 0.134 | Quarterly Revenue Growth 0.07 |
The market value of Tekla Life Sciences is measured differently than its book value, which is the value of Tekla that is recorded on the company's balance sheet. Investors also form their own opinion of Tekla Life's value that differs from its market value or its book value, called intrinsic value, which is Tekla Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tekla Life's market value can be influenced by many factors that don't directly affect Tekla Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tekla Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tekla Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tekla Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.